ZOLGENSMA INTRATHECAL
Live / Allowed — Notice of allowance issued (as of 07 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99114521
- Mark type
- Stylized text
- Filed
- 01 Apr 2025
- Published for opposition
- 10 Jun 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and gene therapy products in the nature of injectable biological preparations for the treatment of genetic, neurological, motor neuron, and neuromuscular diseases, disorders, and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials, sold as a unit, for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials, sold as a unit, for sustained survival motor neuron protein expression being for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jun 2025 — PUBLISHED FOR OPPOSITION
- 04 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 May 2025 — EXAMINER'S AMENDMENT ENTERED
- 06 May 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 06 May 2025 — EXAMINERS AMENDMENT E-MAILED
- 06 May 2025 — EXAMINERS AMENDMENT -WRITTEN
- 30 Apr 2025 — ASSIGNED TO EXAMINER
- 01 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 01 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Apr 2025 — NEW APPLICATION ENTERED